Inaktiver Wert

Andere Sprachen VolitionRX Ltd OTC Bulletin Board

Aktien

VNRX

US9286611077

VNRX

Biotechnologie

Andere Sprachen

08.06.	VolitionRx Announces Pricing of $4.6 Million Public Offering
03.06.	VolitionRx Files Patent for Nu.Q NETs Test in Ebola Triage and Monitoring
03.06.	VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring
03.06.	VolitionRx Limited Files New Patent Application Covering Nu.Q NETs Test For Ebola Triage And Treatment Monitoring
28.05.	VolitionRx : Short Corporate Deck, May 2026
28.05.	VolitionRx : Corporate Presentation May 2026
27.05.	VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
15.05.	Mickie Henshall Not to Stand for Re-Election as Board of Directors of VolitionRx Limited
15.05.	VolitionRx : Short Corporate Deck, May 2026
15.05.	VolitionRx : Corporate Presentation May 2026
15.05.	VolitionRX: Q1 Earnings Snapshot
14.05.	VolitionRx Limited announces first quarter 2026 financial results
14.05.	VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
14.05.	VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
11.05.	VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
06.05.	VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats
06.05.	VolitionRx Limited Announces Submission for Peer Review of Clinical Manuscript Reporting High Accuracy of Nu.Q Vet Feline Prototype Assay in Detecting Lymphoma in Cats
29.04.	Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing
23.04.	VolitionRx Announces Acceptance of Compliance Plan by NYSE American
20.04.	Volition Launches rNuQ™ Webshop Broadening Product Range
20.04.	VolitionRx Limited Launches rNuQ Webshop Broadening Product Range
01.04.	VolitionRx : Short Corporate Deck, Apr 2026
01.04.	VolitionRx : Corporate Presentation April 2026
01.04.	VolitionRX: Q4 Earnings Snapshot
31.03.	VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2025